Negotiation history of PDUFA and GDUFA and lessons for future cycles Negotiation History of PDUFA and GDUFA and Lessons for Future Cycles Introduction to User Fee Acts In the complex landscape of pharmaceutical and device regulation, the User Fee Acts have played a pivotal role under the jurisdiction of the U.S. Food and Drug Administration (FDA). These acts, specifically the Prescription Drug User Fee Act (PDUFA) and the Generic Drug User Fee Amendments (GDUFA), provide crucial financial support for the FDA’s drug and device review processes. This article delves into the historical negotiations surrounding these acts, elucidating their evolutionary trajectory…

Alignment of User Fee Timelines with EMA and Other Global Agencies Alignment of User Fee Timelines with EMA and Other Global Agencies User fee acts are critical components of the regulatory framework that govern the approval process of pharmaceuticals and medical devices. In the United States, the Food and Drug Administration (FDA) operates under several user fee programs, including the Prescription Drug User Fee Act (PDUFA), the Generic Drug User Fee Amendments (GDUFA), the Biosimilar User Fee Act (BsUFA), and the Medical Device User Fee Amendments (MDUFA). Understanding the interaction and alignment of these timelines with the European Medicines Agency…

Facility fee implications for CMOs CDMOs under GDUFA and MDUFA Understanding Facility Fee Implications for CMOs and CDMOs under GDUFA and MDUFA Introduction to User Fee Acts: PDUFA, GDUFA, BsUFA, and MDUFA The U.S. Food and Drug Administration (FDA) operates under various user fee acts that facilitate innovation while ensuring the agency has the necessary resources to effectively regulate the drug and device industries. The user fee acts include the Prescription Drug User Fee Act (PDUFA), the Generic Drug User Fee Amendments (GDUFA), the Biosimilar User Fee Act (BsUFA), and the Medical Device User Fee Amendments (MDUFA). Each act has…

Case Studies of How User Fee Goals Impacted Regulatory and Commercial Strategy Case Studies of How User Fee Goals Impacted Regulatory and Commercial Strategy User fee acts play a critical role in shaping the regulatory landscape in the pharmaceutical, biotechnology, and medical device industries. Regulatory professionals and commercial strategists must understand the impact of these acts on review timelines and overall regulatory strategy. This tutorial aims to provide a detailed examination of how user fee goals, particularly under PDUFA, GDUFA, BsUFA, and MDUFA, have influenced regulatory outcomes and commercial strategies. Understanding User Fee Acts and Their Importance Since the enactment…

Future Directions for User Fee Acts in Digital, AI, and Platform Product Spaces Future Directions for User Fee Acts in Digital, AI, and Platform Product Spaces In recent years, the landscape of the pharmaceutical and biotechnology industries has witnessed rapid advancements, notably influenced by digital technology, artificial intelligence (AI), and innovative platform-based products. As these sectors evolve, understanding the regulatory environment, particularly the User Fee Acts (UFAs) established by the FDA, becomes imperative for industry professionals. This step-by-step tutorial aims to elucidate the current framework of UFAs, including PDUFA, GDUFA, BsUFA, MDUFA review timelines, and their future directions as they…

User Fee Policies for Combination Products and Complex Generics Understanding User Fee Acts: Overview and Importance The regulatory landscape in the United States, particularly with respect to pharmaceutical and device products, is characterized by a series of User Fee Acts that streamline the review process while ensuring safety and efficacy. The Prescription Drug User Fee Act (PDUFA), the Generic Drug User Fee Amendments (GDUFA), the Biosimilar User Fee Act (BsUFA), and the Medical Device User Fee Amendment (MDUFA) play vital roles in shaping the FDA’s operations and regulatory framework. The integration of user fee policies into the approval processes for…

Training Finance and Portfolio Teams on User Fee Act Basics and Impacts Understanding the User Fee Acts: A Guide for Finance and Portfolio Teams Introduction to User Fee Acts The User Fee Acts are fundamental pieces of legislation that enable the U.S. Food and Drug Administration (FDA) to collect fees from pharmaceutical, biotechnology, and medical device companies to help expedite the review process for new drugs and devices. This article provides a comprehensive overview of the various user fee acts, specifically the Prescription Drug User Fee Act (PDUFA), the Generic Drug User Fee Act (GDUFA), the Biosimilar User Fee Act…

Risk Management When User Fee Timelines Slip or Review Clocks Stop The management of timelines within the context of user fee acts such as PDUFA, GDUFA, BsUFA, and MDUFA is critical for ensuring that pharmaceutical and medical device products are reviewed and approved efficiently. The FDA’s commitment to review goals is underpinned by these acts, which facilitate timely access to new therapies for patients while providing an avenue for regulated entities to understand their obligations and expectations. Understanding User Fee Acts User fee acts are legislative frameworks that enable the FDA to collect fees from pharmaceutical and biotechnology companies to…

Internal Dashboards for Monitoring User Fee Dates and Review Milestones Creating Internal Dashboards for User Fee Acts and Review Timelines In the rapidly evolving pharmaceutical and biotechnology sectors, it is crucial for professionals involved in regulatory affairs, clinical operations, and medical affairs to maintain a clear understanding of the user fee acts, including PDUFA, GDUFA, BsUFA, and MDUFA. These user fee acts not only influence review milestones for regulatory submissions but also play a significant role in budgeting and resource allocation within organizations. This comprehensive tutorial will guide you through the process of creating internal dashboards designed for monitoring user…

Tracking User Fee Invoices, Payments and Cover Sheet Details The FDA’s user fee programs, including the Prescription Drug User Fee Act (PDUFA), the Generic Drug User Fee Amendments (GDUFA), the Biosimilar User Fee Act (BsUFA), and the Medical Device User Fee Amendments (MDUFA), are critical in facilitating the review process for drug and device approvals. This tutorial provides a comprehensive guide to tracking user fee invoices, payments, and related cover sheet details essential for pharmaceutical professionals, clinical operations, regulatory affairs, and medical affairs. In meeting FDA expectations, understanding these requirements is paramount in ensuring compliance with the user fee acts….